Compare · CHE vs LFMD
CHE vs LFMD
Side-by-side comparison of Chemed Corp (CHE) and LifeMD Inc. (LFMD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CHE and LFMD operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- CHE is the larger of the two at $5.67B, about 25.7x LFMD ($220.5M).
- Over the past year, CHE is down 23.9% and LFMD is down 62.9% - CHE leads by 39.0 points.
- CHE has been more active in the news (11 items in the past 4 weeks vs 3 for LFMD).
- LFMD has more recent analyst coverage (11 ratings vs 6 for CHE).
- Company
- Chemed Corp
- LifeMD Inc.
- Price
- $426.96+2.27%
- $4.56-2.56%
- Market cap
- $5.67B
- $220.5M
- 1M return
- +0.32%
- -10.41%
- 1Y return
- -23.92%
- -62.94%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 11
- 3
- Recent ratings
- 6
- 11
Chemed Corp
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
LifeMD Inc.
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a medical device for male and female hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; Nava MD, a female-oriented tele-dermatology and skincare brand that would offer virtual medical treatment from dermatologists and other providers; and iNR Wellness MD, a supplement for immune and digestive support. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is based in New York, New York.
Latest CHE
- Director Walsh George J Iii sold $218,915 worth of Capital Stock (500 units at $437.83), decreasing direct ownership by 13% to 3,209 units (SEC Form 4)
- Chemed Corp filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Walsh George J Iii was granted 386 units of Capital Stock, increasing direct ownership by 12% to 3,709 units (SEC Form 4)
- Director Mount John Meredith Jr. was granted 386 units of Capital Stock, increasing direct ownership by 42% to 1,316 units (SEC Form 4)
- Director Mccarthy Eileen P was granted 386 units of Capital Stock, increasing direct ownership by 45% to 1,241 units (SEC Form 4)
- Director Lindell Andrea R was granted 386 units of Capital Stock, increasing direct ownership by 7% to 5,925 units (SEC Form 4)
- Director Heaney Christopher J was granted 386 units of Capital Stock, increasing direct ownership by 16% to 2,775 units (SEC Form 4)
- Director Grace Patrick P was granted 386 units of Capital Stock, increasing direct ownership by 12% to 3,723 units (SEC Form 4)
- Director Delyons Ron was granted 386 units of Capital Stock, increasing direct ownership by 23% to 2,052 units (SEC Form 4)
- Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend
Latest LFMD
- LifeMD Appoints Umesh Sripad as Chief Technology Officer
- LifeMD to Participate in Upcoming Investor Conferences
- Chief Financial Officer Kavthekar Atul was granted 337,500 shares (SEC Form 4)
- SEC Form 10-Q filed by LifeMD Inc.
- LifeMD Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form DEFA14A filed by LifeMD Inc.
- SEC Form DEFA14A filed by LifeMD Inc.
- SEC Form DEF 14A filed by LifeMD Inc.
- LifeMD to Report First Quarter 2026 Financial Results on May 6
- LifeMD® Now Offering Eli Lilly and Company's Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management